Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulin*
References (20)
- et al.
High-dose intravenous gammaglobulin for Kawasaki disease
Lancet
(1983) - et al.
High-dose intravenous gammaglobulin for Kawasaki disease
Lancet
(1984) - et al.
High-dose gammaglobulin therapy for Kawasaki disease
J Pediatr
(1987) - et al.
Rickettsia-like bodies and splenitis in Kawasaki disease
Lancet
(1976) - et al.
Does Kawasaki disease have a retroviral etiology?
Lancet
(1986) - et al.
Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms
Am J Cardiol
(1986) - et al.
The treatment of Kawasaki syndrome with intravenous gamma globulin
N Engl J Med
(1986) - et al.
Prevention of coronary artery involvement in Kawasaki disease by early intravenous high-dose gamma globulin
- et al.
Intravenous gamma globulin therapy in Kawasaki disease: trial of low-dose gamma globulin
- et al.
Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease
Am J Dis Child
(1989)
There are more references available in the full text version of this article.
Cited by (69)
Treatment of Kawasaki disease
2023, Journal de Pediatrie et de PuericultureKawasaki Disease
2017, The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic ApproachesKAWASAKI DISEASE
2009, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth EditionKawasaki Disease
2006, Vascular Medicine: A Companion to Braunwald's Heart DiseaseKawasaki disease
2006, Vascular Medicine
- *
Supported by a grant from Baxter Healthcare Corporation, Hyland Division, Glendale, Calif., and the American Red Cross.
Copyright © 1997 Published by Mosby, Inc.